UROREC

This brand name is authorized in Austria, Australia, Cyprus, Germany, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Poland, Romania, Tunisia, Turkey

Active ingredients

The drug UROREC contains one active pharmaceutical ingredient (API):

1 Silodosin UNII CUZ39LUY82 - SILODOSIN

Silodosin is highly selective for α1A-adrenoreceptors that are primarily located in the human prostate, bladder base, bladder neck, prostatic capsule and prostatic urethra. Blockade of these α1A-adrenoreceptors causes smooth muscle in these tissues to relax, thus decreasing bladder outlet resistance, without affecting detrusor smooth muscle contractility. Read about Silodosin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
UROREC Hard capsule	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04CA04	Silodosin	G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CA Alpha-adrenoreceptor antagonists
Discover more medicines within G04CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 12077P, 12079R
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 06476198, 06476206, 06476229, 06476235, 08806027, 08806033, 09284275, 09284281, 09493441, 09674409, 09715568, 13589170, 15994644
Country: EE	Ravimiamet	Identifier(s): 1459548, 1459559, 1459560, 1459571, 1459582, 1459593, 1459605, 1459616, 1459627, 1459638, 1459649, 1459650, 1459661, 1459672
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 09608004, 09608004IP, 09608011, 09608011IP, 09608011IP1, 09608011IP2, 09608011IP3
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 124714, 474180, 533694
Country: FR	Base de données publique des médicaments	Identifier(s): 65024515, 69141416
Country: IE	Health Products Regulatory Authority	Identifier(s): 13220, 47500, 47512, 47513, 47540, 47541
Country: IT	Agenzia del Farmaco	Identifier(s): 039789045, 039789110
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1053026, 1053027, 1053028, 1053029, 1053030, 1053031, 1053032, 1053035, 1053036, 1053037, 1053038, 1053039, 1053040, 1053041
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100074739, 100292710
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W56136001, W56136002, W56136003, W56136004, W56136005, W56136006, W56136007, W56137001, W56137002, W56137003, W56137004, W56137005, W56137006, W56137007
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 14223011, 14223012
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699559150087, 8699559150094